Financial statements Bioceltix
Cash flow statement of Bioceltix
Company age:
Age:
7 y. 3 m. 28 d.
Share capital:
Share capital:
198 150 PLN
Cash inflows of BIOCELTIX
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Net cash from operating expenses | -1 779 055,95 | -1 667 755,53 | -1 675 182,82 | -4 018 343,82 |
| Net cash flow from investing activities | -523 195,93 | -179 667,73 | -13 909,00 | 134 056,56 |
| Net cash flow from financial activities | 1 488 132,91 | 1 377 671,21 | 3 791 229,33 | 6 735 158,23 |
| Total net cash flow | -814 118,97 | -469 752,05 | 2 102 137,51 | 2 850 870,97 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.